Status:
COMPLETED
Thin-Flap Laser in Situ Keratomileusis Associated Dry Eye
Lead Sponsor:
Assiut University
Conditions:
Myopic LASIK Candidates With Spherical Equivalent up to - 10 Diopters
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Laser in situ keratomileusis (LASIK) eye surgery continues to be the most common refractive procedure used to correct different forms of ametropia. Although the introduction of femtosecond technology ...
Detailed Description
The pathophysiology of post LASIK dry eye is not clear; however, many mechanisms have been suggested including inflammation, loss of conjunctival goblet cells during suction, exacerbation of a preexis...
Eligibility Criteria
Inclusion
- Candidates for Laser Vision Correction (LVC).
- Eyes with spherical equivalent (SE) up to - 10 diopters (D),
- Corneal thickness at thinnest location of ≥ 500 um and estimated postoperative residual stromal bed of at least 300 um
Exclusion
- Patients with symptoms or signs of dry eye (TBUT \<10 sec, Schirmer I test \<10mm and Ocular Surface Disease Index OSDI score \>13),
- Posterior blepharitis, contact lens wearers ,
- Ocular surface disease ,
- Systemic diseases contraindicating LASIK and previous ocular surgery.
Key Trial Info
Start Date :
June 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2020
Estimated Enrollment :
55 Patients enrolled
Trial Details
Trial ID
NCT04831177
Start Date
June 1 2019
End Date
September 1 2020
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TIBA eye center
Asyut, Egypt, 71516